Albayda, J., Pinal-Fernandez, I., Huang, W., Parks, C., Paik, J., Casciola-Rosen, L., . . . Mammen, A. L. (2017). Dermatomyositis Patients with Anti-Nuclear Matrix Protein-2 Autoantibodies Have More Edema, More Severe Muscle Disease, and Increased Malignancy Risk. Arthritis Care Res (Hoboken).
Chicago Stili AlıntıAlbayda, Jemima, et al. "Dermatomyositis Patients With Anti-Nuclear Matrix Protein-2 Autoantibodies Have More Edema, More Severe Muscle Disease, and Increased Malignancy Risk." Arthritis Care Res (Hoboken) 2017.
MLA AlıntıAlbayda, Jemima, et al. "Dermatomyositis Patients With Anti-Nuclear Matrix Protein-2 Autoantibodies Have More Edema, More Severe Muscle Disease, and Increased Malignancy Risk." Arthritis Care Res (Hoboken) 2017.